SNL BioSolutions ApS
CVR 44569272 · Private limited company (ApS) · Active · Medium risk
SNL BioSolutions ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -4.7m and a net result of DKK -1.8m. CEO: Dayanand Suryabhan Jadhav.
Bankruptcy risk for SNL BioSolutions ApS
1.3 × the average (1.41%) · higher risk than 81% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44569272
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Hagens Alle 7
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 470k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -701.0% |
| Current ratio | 109% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -607k | DKK -1.5m |
| Net profit | DKK -1.8m | DKK -3.9m |
| Equity | DKK -4.7m | DKK -3.9m |
| Total assets | DKK 671k | DKK 881k |
| Cash | DKK 500k | DKK 751k |
| Short-term debt | DKK 527k | DKK 111k |
| Avg. employees | 3 | 6 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 135 | ||
| 17 Jan 2024 – 31 Dec 2024 | 154 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Dayanand Suryabhan Jadhav | Current | |
| Board | Dayanand Suryabhan Jadhav | Current | |
| Board | Jarne Elleholm | ||
| Owner (90%) | SNLB Holding ApS | Current | |
| Owner (100%) | SNLB Holding ApS | ||
| Owner (5%) | LEEWARD ApS | ||
| Owner (67%) | SNLB Holding ApS | ||
| Owner (5%) | Ambareesh Govind Phadnavis | ||
| Founder | SNLB Holding ApS | Current |
The CEOs' other companies
Dayanand Suryabhan Jadhav – 4 other companies
- Dayanand Jadhav Holding ApS Active
- G2B BioSolutions ApS Active
- G2B BioSolutions Denmark ApS Opløst
- SNLB Holding ApS Active
Address history (0 moves)
| Hagens Alle 7, 2900 Hellerup |
Other companies at the same address
- A.C. BENDIXEN BILER ApS Opløst
- Dayanand Jadhav Holding ApS Active
- G2B BioSolutions ApS Active
- G2B BioSolutions Denmark ApS Opløst
- M B EJENDOMME ApS Opløst
- M B INVEST ApS Opløst
- NORDKYSTENS IMPORT ApS Opløst
- SNLB Holding ApS Active
Similar companies in Gentofte
- NIVI Development A/S Hellerup
- Neo Biopharm ApS Hellerup
- G2B BioSolutions ApS Hellerup
- Beatsco2 ApS Charlottenlund
- MHJ Research ApS Hellerup
- XY Therapeutics ApS Charlottenlund
- Lophora ApS Charlottenlund
- CABA APS Charlottenlund
- Devopharma ApS Charlottenlund
- C- ApS Hellerup
- UNION therapeutics A/S Hellerup
- Aktieselskabet af 1. juni 2011 II Hellerup
Questions and answers about SNL BioSolutions ApS
Has SNL BioSolutions ApS gone bankrupt?
No, SNL BioSolutions ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SNL BioSolutions ApS?
Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.
Who is the CEO of SNL BioSolutions ApS?
Dayanand Suryabhan Jadhav is the CEO of SNL BioSolutions ApS.
When was SNL BioSolutions ApS founded?
SNL BioSolutions ApS was founded on 17 January 2024.
What is the equity of SNL BioSolutions ApS?
Equity was DKK -4.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.